What an incredible few days at Jefferies & London Life Science Week! 🎉 A huge thank you to Jefferies, the BioIndustry Association (BIA), MedCity, and London & Partners for hosting this goliath event. It gets bigger, better and more impactful every year, and we’re proud to be part of it. We are glad so many […]
Internationally recognized clinical strategist with proven track record in translating innovation into clinical impact joins Domain to advance its GPCR-targeting pipeline Appointment comes at a pivotal moment, following the initiation of Phase I/II development of DT-7012, a Treg-depleting anti-CCR8 antibody candidate Strasbourg, France – Montreal, Canada – Boston, United States, November 13, 2025: Domain Therapeutics […]
Investment firms Quantum VC firm 55 North launched with first close of its €300 million inaugural Fund I at €134 million French VC Andera Partners closed its seventh fund, Biodiscovery Fund 7, with more than €300 million to invest in U.S. and European companies ranging from startup/early stage to scale up and late stage. GHO […]
You’d expect us here at Optimum Strategic Communications to be excited about Nobel Prize season – particularly the gongs for the two categories of Physiology or Medicine and Chemistry. And we have been. But it’s this year’s Nobel Prize for Economic Sciences that really caught our eye, because it has major implications for the life […]
Third cohort of cross-organizational, high-level mentorship program to commence in November 2025 Continued support from the Lundbeck Foundation and the Novo Nordisk Foundation WiLD celebrates its third anniversary with 250+ members in Denmark 28 October 2025, Denmark: Women in Life Science Denmark (WiLD) today announces that it is launching the third cohort of its successful […]
